✦ LIBER ✦

Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial

✍ Scribed by Martin F Muers; Richard J Stephens; Patricia Fisher; Liz Darlison; Christopher MB Higgs; Erica Lowry; Andrew G Nicholson; Mary O'Brien; Michael Peake; Robin Rudd; Michael Snee; Jeremy Steele; David J Girling; Matthew Nankivell; Cheryl Pugh; Mahesh KB Parmar

Book ID: 117302962
Publisher: The Lancet
Year: 2008
Tongue: English
Weight: 231 KB
Volume: 371
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(08)60727-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

4BA Active symptom control (ASC) with or

4BA Active symptom control (ASC) with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma. The UK Medical Research Council/British Thoracic Society MS01 randomised clinical trial

✍ M. Muers; P. Fisher; M. O'Brien; M. Peake; R. Rudd; M. Snee; J. Steele; M. Nanki 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 45 KB

O-25 A feasibility study of active sympt

O-25 A feasibility study of active symptom control (ASC) with or without chemotherapy in malignant pleural mesothelioma

✍ Muers, Martin F.; Rudd, Robin; Hodson, Adrian; Owen, Robert; Qian, Wendi; Stephe 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Malignant Pleural Mesothelioma Patients’

Malignant Pleural Mesothelioma Patients’ Willingness to Participate in a Randomized Controlled Trial of Radical Pleurectomy With or Without Intraoperative Photodynamic Therapy

✍ Shah, A.; Culligan, M.; Friedberg, J.S.; Sterman, D.H.; Alley, E.; Stevenson, J. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Thalidomide versus active supportive car

Thalidomide versus active supportive care for maintenance in patients with malignant mesothelioma after first-line chemotherapy (NVALT 5): an open-label, multicentre, randomised phase 3 study

✍ Buikhuisen, Wieneke A; Burgers, Jacobus A; Vincent, Andrew D; Korse, Catharina M 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 363 KB

Cisplatin in combination with irinotecan

Cisplatin in combination with irinotecan in the treatment of patients with malignant pleural mesothelioma : A pilot phase II clinical trial and pharmacokinetic profile

✍ Takashi Nakano; A. Philippe Chahinian; Miho Shinjo; Naoki Togawa; Atsushi Tonomu 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB 👁 2 views

The purpose of this study was to assess the efficacy and toxicity of a combination of cisplatin and irinotecan (CPT-11) in the treatment of patients with malignant pleural mesothelioma and to characterize the pharmacokinetic profiles of CPT-11 and its active metabolite, 7-ethyl-10-hydroxycamptotheci

Efficacy and cost of video-assisted thor

Efficacy and cost of video-assisted thoracoscopic partial pleurectomy versus talc pleurodesis in patients with malignant pleural mesothelioma (MesoVATS): an open-label, randomised, controlled trial

✍ Rintoul, Robert C; Ritchie, Andrew J; Edwards, John G; Waller, David A; Coonar, 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 432 KB